Ezh2 Ameliorates Osteoarthritis by Activating TNFSF13B

Epigenetic regulation is highly correlated with osteoarthritis (OA) development, whereas its role and detailed mechanisms remain elusive. In this study, we explored the expression of EZH2, an H3K27me3 transferase, in human OA cartilages and its roles in regulating OA pathogenesis. Here, we found EZH2 was highly expressed in both mice and human OA cartilage samples by using histological analysis and RNA sequencing (RNA‐Seq). The medial meniscectomy (MMx) OA model results indicated the conditional knockout of Ezh2 deteriorated OA pathological conditions. Furthermore, we showed the positive role of Ezh2 in cartilage wound healing and inhibition of hypertrophy through activating TNFSF13B, a member of the tumor necrosis factor superfamily. Further, we also indicated that the effect of TNFSF13B, increased by Ezh2, might boost the healing of chondrocytes through increasing the phosphorylation of Akt. Taken together, our results uncovered an EZH2‐positive subpopulation existed in OA patients, and that EZH2‐TNFSF13B signaling was responsible for regulating chondrocyte healing and hypertrophy. Thus, EZH2 might act as a new potential target for OA diagnosis and treatment. © 2020 American Society for Bone and Mineral Research.

[1]  Xiaoshun He,et al.  Let‐7e inhibits TNF‐α expression by targeting the methyl transferase EZH2 in DENV2‐infected THP‐1 cells , 2018, Journal of cellular physiology.

[2]  A. V. van Wijnen,et al.  Loss of histone methyltransferase Ezh2 stimulates an osteogenic transcriptional program in chondrocytes but does not affect cartilage development , 2018, The Journal of Biological Chemistry.

[3]  S. Lim,et al.  MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. , 2018, Biomaterials.

[4]  F. Watt,et al.  Osteoarthritis biomarkers: year in review. , 2017, Osteoarthritis and cartilage.

[5]  S. Um,et al.  Synovial cell death is regulated by TNF-α-induced expression of B-cell activating factor through an ERK-dependent increase in hypoxia-inducible factor-1α , 2017, Cell Death & Disease.

[6]  Shouan Zhu,et al.  Kdm6b regulates cartilage development and homeostasis through anabolic metabolism , 2017, Annals of the rheumatic diseases.

[7]  W. Gong,et al.  Chicoric acid suppresses BAFF expression in B lymphocytes by inhibiting NF‐&kgr;B activity , 2017, International immunopharmacology.

[8]  Philip G Conaghan,et al.  Synovitis in osteoarthritis: current understanding with therapeutic implications , 2017, Arthritis Research & Therapy.

[9]  J. Baron,et al.  EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy , 2016, Nature Communications.

[10]  Fangcai Li,et al.  The inhibition of EZH2 ameliorates osteoarthritis development through the Wnt/β-catenin pathway , 2016, Scientific Reports.

[11]  C. Christiansen,et al.  Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment? , 2016, Scandinavian journal of rheumatology.

[12]  D. Speicher,et al.  Three-dimensional culture sensitizes epithelial ovarian cancer cells to EZH2 methyltransferase inhibition , 2013, Cell cycle.

[13]  L. R. Carpio,et al.  Histone Deacetylase 3 Suppression Increases PH Domain and Leucine-rich Repeat Phosphatase (Phlpp)1 Expression in Chondrocytes to Suppress Akt Signaling and Matrix Secretion* , 2013, The Journal of Biological Chemistry.

[14]  L. Papon,et al.  The TNF family member APRIL dampens collagen-induced arthritis , 2012, Annals of the rheumatic diseases.

[15]  A. P. Graves,et al.  Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2. , 2012, ACS medicinal chemistry letters.

[16]  G. Verbruggen,et al.  Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification , 2011, Annals of the rheumatic diseases.

[17]  Qiang Yu,et al.  Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers. , 2011, Molecular cell.

[18]  Sung-Hwan Park,et al.  Regulation of B cell activating factor (BAFF) receptor expression by NF-κB signaling in rheumatoid arthritis B cells , 2011, Experimental & Molecular Medicine.

[19]  Guang Xu,et al.  A role of both NF-κB pathways in expression and transcription regulation of BAFF-R gene in multiple myeloma cells , 2011, Molecular and Cellular Biochemistry.

[20]  B. Dijkmans,et al.  Treatment with TNF-α inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis. , 2010, Osteoarthritis and cartilage.

[21]  N Maffulli,et al.  Evaluation of histological scoring systems for tissue-engineered, repaired and osteoarthritic cartilage. , 2010, Osteoarthritis and cartilage.

[22]  F. Dell’Accio,et al.  A novel in vivo murine model of cartilage regeneration. Age and strain-dependent outcome after joint surface injury , 2009, Osteoarthritis and cartilage.

[23]  H. Cheon,et al.  B cell activation factor (BAFF) is a novel adipokine that links obesity and inflammation , 2009, Experimental & Molecular Medicine.

[24]  M. Turner,et al.  B‐cell responses to B‐cell activation factor of the TNF family (BAFF) are impaired in the absence of PI3K delta , 2008, European journal of immunology.

[25]  C. Little,et al.  Evidence for articular cartilage regeneration in MRL/MpJ mice. , 2008, Osteoarthritis and cartilage.

[26]  M. Goldring,et al.  Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism , 2008, Annals of the rheumatic diseases.

[27]  C. Little,et al.  Evidence for articular cartilage regeneration in MRL/MpJ mice. , 2008, Osteoarthritis and cartilage.

[28]  E. Lefèvre,et al.  BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. , 2008, Blood.

[29]  R. O’Keefe,et al.  Generation of a transgenic mouse model with chondrocyte‐specific and tamoxifen‐inducible expression of Cre recombinase , 2007, Genesis.

[30]  Boon Chin Heng,et al.  Osteoarthritis and therapy. , 2006, Arthritis and rheumatism.

[31]  S. Jimenez,et al.  Osteoarthritis cartilage histopathology: grading and staging. , 2006, Osteoarthritis and cartilage.

[32]  Kozo Nakamura,et al.  Osteoarthritis development in novel experimental mouse models induced by knee joint instability. , 2005, Osteoarthritis and cartilage.

[33]  A. Rosenwald,et al.  BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma , 2005, The Journal of experimental medicine.

[34]  T. Kipps,et al.  Fibroblast-Like Synoviocytes of Mesenchymal Origin Express Functional B Cell-Activating Factor of the TNF Family in Response to Proinflammatory Cytokines1 , 2005, The Journal of Immunology.

[35]  I. Wicks,et al.  Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. , 2001, The Journal of clinical investigation.

[36]  K Henriksen,et al.  Osteoarthritis--a case for personalized health care? , 2014, Osteoarthritis and cartilage.

[37]  Johanne Martel-Pelletier,et al.  Role of proinflammatory cytokines in the pathophysiology of osteoarthritis , 2011, Nature Reviews Rheumatology.

[38]  D. Saris,et al.  Evaluation of histological scoring systems for tissue-engineered, repaired and osteoarthritic cartilage. , 2010, Osteoarthritis and cartilage.

[39]  R. Moskowitz.  Osteoarthritis cartilage histopathology: grading and staging. , 2006, Osteoarthritis and cartilage.